CD19 and acute lymphoblastic leukemia: The missense and frameshift mutations in exon 2 of the CD19 gene, as well as alternative splice variants lacking exon 2 or exons 5–6, were detected in samples from relapsed B-ALL patients after CD19 CAR-T therapy [101].